Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
Add more filters










Publication year range
3.
Int J Dermatol ; 30(11): 774-5, 1991 Nov.
Article in English | MEDLINE | ID: mdl-1757178
4.
J Am Acad Dermatol ; 22(2 Pt 1): 199-203, 1990 Feb.
Article in English | MEDLINE | ID: mdl-2138172

ABSTRACT

A double-blind, paired comparison study was used to evaluate treatment effects of 12% ammonium lactate lotion (Lac-Hydrin) against its vehicle on seborrheic keratoses. Fifty-eight volunteer patients, 37 to 82 years of age, were studied for 16 weeks. The patients had a minimum of two seborrheic keratoses at least 10 cm apart. They applied the medication twice daily. The lesions were evaluated for height, surface characteristics, color, and length with the use of 7X calibrated loupe, a template, skin replicas, and scanning electron microscopy. Lac-Hydrin 12% lotion significantly reduced the height (elevation) of seborrheic keratoses, and two seborrheic keratoses cleared completely; however, there was no statistically significant difference in the length, color, and surface characteristics between the study group and the control group. Skin replicas and scanning electron microscopy can be used to evaluate lesion surface characteristics, dimensions, and therapeutic effects.


Subject(s)
Dermatitis, Seborrheic/drug therapy , Keratosis/drug therapy , Lactates/therapeutic use , Dermatitis, Seborrheic/pathology , Double-Blind Method , Emollients/therapeutic use , Humans , Keratosis/pathology , Lactic Acid , Microscopy, Electron, Scanning , Skin Pigmentation
5.
Pharmacotherapy ; 10(2): 107-11, 1990.
Article in English | MEDLINE | ID: mdl-2349135

ABSTRACT

The effects on the hypothalamic-pituitary-adrenal axis of the ultra-high potency corticosteroid halobetasol in the treatment of psoriasis were evaluated in seven patients with extensive, long-standing plaque psoriasis. Each patient applied 3.5 g halobetasol 0.05% ointment in the morning and evening for 7 days. Morning plasma cortisol levels and 24-hour urinary excretion of 17-hydroxycorticosteroid were determined before and on the last 2 days of treatment; plasma cortisol levels were also determined 4 and 5 days after completion of therapy. Morning plasma cortisol concentrations did not decrease significantly during treatment, and no values were below the normal range. Mean 24-hour urinary 17-hydroxycorticosteroid excretion fell from 6.6 +/- 1.4 mg to 5.1 +/- 1.4 mg. Two patients had mild, localized pruritus and stinging with the initial ointment application. No other adverse cutaneous effects were observed. Halobetasol was also clinically efficacious over the 7 days of treatment, based on evaluation of pruritus, erythema, scaling, and plaque elevation. These results demonstrate no adverse effects of the drug on the hypothalamic-pituitary-adrenal axis at doses that are clinically effective in the management of plaque psoriasis.


Subject(s)
Betamethasone/analogs & derivatives , Clobetasol/analogs & derivatives , Hypothalamo-Hypophyseal System/drug effects , Pituitary-Adrenal System/drug effects , Psoriasis/drug therapy , 17-Hydroxycorticosteroids/urine , Adult , Aged , Clobetasol/pharmacology , Clobetasol/therapeutic use , Drug Evaluation , Female , Humans , Hydrocortisone/blood , Male , Middle Aged , Ointments , Psoriasis/blood , Psoriasis/urine , Time Factors
6.
J Am Acad Dermatol ; 21(5 Pt 1): 979-84, 1989 Nov.
Article in English | MEDLINE | ID: mdl-2808834

ABSTRACT

Compounding compatibility studies of four corticosteroid cream products and four commonly added chemicals are presented. Physical alteration, chemical stability, micropreservative challenge status, and in vitro skin penetration were evaluated at ambient conditions for 2 months. The study was designed to generate useful, previously unavailable information to aid dispensing pharmacists and dermatologists.


Subject(s)
Anti-Inflammatory Agents/pharmacokinetics , Skin Absorption/physiology , Administration, Topical , Chemical Phenomena , Chemistry , Desoximetasone/pharmacokinetics , Drug Compounding , Fluocinonide/pharmacokinetics , Hydrocortisone/analogs & derivatives , Hydrocortisone/pharmacokinetics , Triamcinolone Acetonide/pharmacokinetics
7.
J Am Acad Dermatol ; 21(4 Pt 1): 714-6, 1989 Oct.
Article in English | MEDLINE | ID: mdl-2808786

ABSTRACT

This double-blind study was designed to evaluate treatment results and time effects of 12% ammonium lactate and 5% lactic acid lotion for moderate to severe xerosis. Results showed 12% ammonium lactate lotion was significantly more effective than 5% lactic acid lotion in reducing the severity of xerosis in both the 3-week, twice-a-day treatment period and the following 3-week, no-treatment (regression) period.


Subject(s)
Ichthyosis/drug therapy , Lactates/therapeutic use , Adult , Aged , Double-Blind Method , Drug Evaluation , Female , Humans , Lactic Acid , Male , Middle Aged , Severity of Illness Index
8.
J Am Acad Dermatol ; 20(5 Pt 1): 744-8, 1989 May.
Article in English | MEDLINE | ID: mdl-2715428

ABSTRACT

We have used a specially modified xenon arc solar simulator to examine ultraviolet A (UVA) protection of a research sunscreen formulation. UVA doses were given to sunscreen-protected and unprotected skin with the use of irradiance values of 50 mW/cm2 and 100 mW/cm2. Erythemal responses were evaluated 5.2 +/- 0.9 hours later and again 24.4 +/- 1.8 hours later. The overall mean unprotected UVA minimal erythema dose (MED) was 23.6 joules/cm2 (SD = 4.8) and the mean UVA protection factor (APF) was 3.2 (SD = 0.78). Neither irradiance nor evaluation time significantly affected MED or APF. These preliminary findings indicate that the modified solar simulator permits convenient determination of sunscreen APF. The APF of a sunscreen is analogous to SPF: APF refers to UVA protection, while SPF refers to protection from the entire solar spectrum, predominantly from the effects of UVB.


Subject(s)
Skin/radiation effects , Sunscreening Agents/standards , Ultraviolet Rays/adverse effects , Adult , Alpha Particles , Erythema/etiology , Erythema/prevention & control , Female , Humans , Male , Time Factors
10.
Cutis ; 39(6): 512-5, 1987 Jun.
Article in English | MEDLINE | ID: mdl-3608578

ABSTRACT

The symptoms of xerosis (dry skin) can be ameliorated by increasing the hydration state of the stratum corneum through a humectant or occlusive effect, smoothing the rough surface with an emollient, replenishing natural moisturizing factors, and normalizing the stratum corneum. We present the primary and secondary functions of various "active" and vehicle ingredients and include precautions regarding certain classes of materials. Recommendations on selecting moisturizing systems are made based on ingredient functionality and the severity of the dry skin condition.


Subject(s)
Cosmetics , Dermatologic Agents , Skin Diseases/drug therapy , Collagen , Emollients , Humans , Pharmaceutical Vehicles , Preservatives, Pharmaceutical , Surface-Active Agents
11.
J Am Acad Dermatol ; 15(6): 1253-8, 1986 Dec.
Article in English | MEDLINE | ID: mdl-3543073

ABSTRACT

Lactate 12% lotion was significantly more effective than both its vehicle and a petrolatum-based cream in the treatment of ichthyosis. The treatment regimen was twice-daily application for 4 weeks with evaluations weekly during the treatment period and for 2 weeks after treatment was stopped. Vulgaris, lamellar, sex-linked, Netherton's, and epidermolytic hyperkeratotic forms of ichthyosis were significantly improved by treatment with lactate 12% lotion. This new therapeutic modality expands the scope and extent of ichthyotic conditions that may now be successfully treated.


Subject(s)
Ichthyosis/drug therapy , Lactates/therapeutic use , Petrolatum/therapeutic use , Administration, Topical , Adolescent , Adult , Aged , Aged, 80 and over , Child , Child, Preschool , Clinical Trials as Topic , Humans , Ichthyosis/genetics , Lactic Acid , Middle Aged , Pharmaceutical Vehicles
12.
Cutis ; 37(5): 384-5, 1986 May.
Article in English | MEDLINE | ID: mdl-3519103

ABSTRACT

The use of Alpha Keri bath oil in a postshower therapeutic regimen was effective in reducing the severity of moderate to severe xerosis.


Subject(s)
Skin Diseases/drug therapy , Surface-Active Agents/therapeutic use , Adult , Baths , Clinical Trials as Topic , Female , Humans , Middle Aged , Oils/therapeutic use
14.
Cutis ; 37(3): 205-7, 209, 1986 Mar.
Article in English | MEDLINE | ID: mdl-3514154

ABSTRACT

Lactic acid, one of the most widely distributed acids in nature, is present in biological fluids and tissues of humans as an intermediary in carbohydrate metabolism. Alpha-hydroxy acids, including lactic acid, and their salts have been recommended for the treatment of keratinization disorders. This controlled double-blind study compares the efficacy of lactate 12 percent lotion and a petrolatum-based therapeutic creme (creme B) in patients with moderate to severe xerosis. Lactate 12 percent lotion was significantly more effective than a petrolatum-based creme in reducing the severity of xerosis during treatment and post-treatment phases.


Subject(s)
Lactates/administration & dosage , Ointments , Petrolatum/administration & dosage , Skin Diseases/drug therapy , Clinical Trials as Topic , Double-Blind Method , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...